Lenalidomide initially known as CC-5013 and marketed as Revlimid by Celgene
<===
MAGE
http://www.kurzweilai.net/ucsf-fountain-of-youth-pill-could-restore-aging-immune-system
| Price | 72.00 |
| Price Change Today | -$0.86 (-1.18%) |
| P&P rating | ![]() |
| Zacks Rank | 2 - BUY |
| Open Price | $73.15 |
| Previous Close | $72.86 |
| Daily Range | $71.92 - $73.19 |
| 52-Week Range | $50.11 - $74.75 |
| Volume | 4,058,878 |
| Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases. | |




<===
MAGE
http://www.kurzweilai.net/ucsf-fountain-of-youth-pill-could-restore-aging-immune-system
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment